The 1H NMR profile of healthy dog cerebrospinal fluid.

The availability of data for reference values in cerebrospinal fluid for healthy humans is limited due to obvious practical and ethical issues. The variability of reported values for metabolites in human cerebrospinal fluid is quite large. Dogs present great similarities with humans, including in ca...

Full description

Bibliographic Details
Main Authors: Mihai Musteata, Alina Nicolescu, Gheorghe Solcan, Calin Deleanu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3871169?pdf=render
id doaj-54488d21316c4b61b4817ca8ff602be2
record_format Article
spelling doaj-54488d21316c4b61b4817ca8ff602be22020-11-24T21:51:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8119210.1371/journal.pone.0081192The 1H NMR profile of healthy dog cerebrospinal fluid.Mihai MusteataAlina NicolescuGheorghe SolcanCalin DeleanuThe availability of data for reference values in cerebrospinal fluid for healthy humans is limited due to obvious practical and ethical issues. The variability of reported values for metabolites in human cerebrospinal fluid is quite large. Dogs present great similarities with humans, including in cases of central nervous system pathologies. The paper presents the first study on healthy dog cerebrospinal fluid metabolomic profile using (1)H NMR spectroscopy. A number of 13 metabolites have been identified and quantified from cerebrospinal fluid collected from a group of 10 mix breed healthy dogs. The biological variability as resulting from the relative standard deviation of the physiological concentrations of the identified metabolites had a mean of 18.20% (range between 9.3% and 44.8%). The reported concentrations for metabolites may be used as normal reference values. The homogeneity of the obtained results and the low biologic variability show that the (1)H NMR analysis of the dog's cerebrospinal fluid is reliable in designing and interpreting clinical and therapeutic trials in dogs with central nervous system pathologies.http://europepmc.org/articles/PMC3871169?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Mihai Musteata
Alina Nicolescu
Gheorghe Solcan
Calin Deleanu
spellingShingle Mihai Musteata
Alina Nicolescu
Gheorghe Solcan
Calin Deleanu
The 1H NMR profile of healthy dog cerebrospinal fluid.
PLoS ONE
author_facet Mihai Musteata
Alina Nicolescu
Gheorghe Solcan
Calin Deleanu
author_sort Mihai Musteata
title The 1H NMR profile of healthy dog cerebrospinal fluid.
title_short The 1H NMR profile of healthy dog cerebrospinal fluid.
title_full The 1H NMR profile of healthy dog cerebrospinal fluid.
title_fullStr The 1H NMR profile of healthy dog cerebrospinal fluid.
title_full_unstemmed The 1H NMR profile of healthy dog cerebrospinal fluid.
title_sort 1h nmr profile of healthy dog cerebrospinal fluid.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description The availability of data for reference values in cerebrospinal fluid for healthy humans is limited due to obvious practical and ethical issues. The variability of reported values for metabolites in human cerebrospinal fluid is quite large. Dogs present great similarities with humans, including in cases of central nervous system pathologies. The paper presents the first study on healthy dog cerebrospinal fluid metabolomic profile using (1)H NMR spectroscopy. A number of 13 metabolites have been identified and quantified from cerebrospinal fluid collected from a group of 10 mix breed healthy dogs. The biological variability as resulting from the relative standard deviation of the physiological concentrations of the identified metabolites had a mean of 18.20% (range between 9.3% and 44.8%). The reported concentrations for metabolites may be used as normal reference values. The homogeneity of the obtained results and the low biologic variability show that the (1)H NMR analysis of the dog's cerebrospinal fluid is reliable in designing and interpreting clinical and therapeutic trials in dogs with central nervous system pathologies.
url http://europepmc.org/articles/PMC3871169?pdf=render
work_keys_str_mv AT mihaimusteata the1hnmrprofileofhealthydogcerebrospinalfluid
AT alinanicolescu the1hnmrprofileofhealthydogcerebrospinalfluid
AT gheorghesolcan the1hnmrprofileofhealthydogcerebrospinalfluid
AT calindeleanu the1hnmrprofileofhealthydogcerebrospinalfluid
AT mihaimusteata 1hnmrprofileofhealthydogcerebrospinalfluid
AT alinanicolescu 1hnmrprofileofhealthydogcerebrospinalfluid
AT gheorghesolcan 1hnmrprofileofhealthydogcerebrospinalfluid
AT calindeleanu 1hnmrprofileofhealthydogcerebrospinalfluid
_version_ 1725880270365655040